ReShape Lifesciences Inc Cash Flow Quality Index

Latest as of March 2025: -1.44x

ReShape Lifesciences Inc cash flow quality index. ReShape Lifesciences Inc (RSLS) has a Cash Flow Quality Index of -1.44x as of March 2025. Operating cash flow of $-2.12 Million is below net income of $1.47 Million, suggesting accrual-heavy earnings not yet converted to cash. See RSLS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.44x

Operating CF / Net Income

Operating Cash Flow

$-2.12 Million

USD

Net Income

$1.47 Million

USD

Data as of

Mar 2025

Most recent filing

ReShape Lifesciences Inc Cash Flow Quality Index by Year (None–None)

ReShape Lifesciences Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for ReShape Lifesciences Inc. For the full cash flow conversion analysis, see ReShape Lifesciences Inc cash conversion from operations.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.